PSEN1 and familial Alzheimer disease: Inhibition, substrate binding or the PS1 familial Alzheimer disease (FAD)-causing mutation (delta exon 9) remodel the conformational landscape of the protease by enriching specific subpopulations that already pre-exist in the ligand-free state.